1. Present achievements in the medical treatment of metastatic renal cell carcinoma;Ravaud;Crit. Rev. Oncol. Hematol.,1999
2. Multidrug resistance (MDR) modulation in renal cell carcinoma (RCC) using cyclosporin A (CSA) or tamoxifen (CALGB 9163);Samuels;Proc. Am. Soc. Clin. Oncol,1994
3. Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma;Motzer;J. Clin. Oncol,1995
4. Phase II trials with multidrug resistance (MDR) modulation using high dose tamoxifen alone or with quinine in metastatic renal cell carcinoma (MRCC);Ravaud;Proc. Am. Soc. Clin. Oncol,1998
5. Humoral immune response of patients receiving specific active immunotherapy for renal cell carcinoma;Miller;Cancer Res,1985